These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 7237445)
21. Selective depletion of human DNA-methyltransferase DNMT1 proteins by sulfonate-derived methylating agents. Chuang LS; Tan EH; Oh HK; Li BF Cancer Res; 2002 Mar; 62(6):1592-7. PubMed ID: 11912126 [TBL] [Abstract][Full Text] [Related]
22. Effects of 5-(3-methyl-1-triazeno)imidazole-4-carboxamide (NSC-407347), an alkylating agent derived from 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388). Mizuno NS; Decker RW; Zakis B Biochem Pharmacol; 1975 Mar; 24(5):615-9. PubMed ID: 1168474 [No Abstract] [Full Text] [Related]
23. Genotoxic methylating agents modulate extracellular signal regulated kinase activity through MEK-dependent, glutathione-, and DNA methylation-independent mechanisms in lung epithelial cells. Wichmann AE; Thomson NM; Peterson LA; Wattenberg EV Chem Res Toxicol; 2003 Jan; 16(1):87-94. PubMed ID: 12693035 [TBL] [Abstract][Full Text] [Related]
24. Sites in nucleic acids reacting with alkylating agents of differing carcinogenicity of mutagenicity. Singer B J Toxicol Environ Health; 1977 Jul; 2(6):1279-95. PubMed ID: 328918 [TBL] [Abstract][Full Text] [Related]
25. Predictive and mechanistic evaluation to toxic responses in mammalian cell culture systems. Grisham JW; Smith GJ Pharmacol Rev; 1984 Jun; 36(2 Suppl):151S-171S. PubMed ID: 6382353 [No Abstract] [Full Text] [Related]
26. Induction of c-fos, c-jun, junB and junD mRNA and AP-1 by alkylating mutagens in cells deficient and proficient for the DNA repair protein O6-methylguanine-DNA methyltransferase (MGMT) and its relationship to cell death, mutation induction and chromosomal instability. Dosch J; Kaina B Oncogene; 1996 Nov; 13(9):1927-35. PubMed ID: 8934539 [TBL] [Abstract][Full Text] [Related]
27. DNA synthesis, mutagenesis, DNA damage, and cytotoxicity in cultured mammalian cells treated with alkylating agents. Peterson AR Cancer Res; 1980 Mar; 40(3):682-8. PubMed ID: 7471086 [TBL] [Abstract][Full Text] [Related]
28. Adducts of N-terminal valines in hemoglobin with isoprene diepoxide, a metabolite of isoprene. Fred C; Cantillana T; Henderson AP; Golding BT; Törnqvist M Rapid Commun Mass Spectrom; 2004; 18(18):2177-84. PubMed ID: 15378724 [TBL] [Abstract][Full Text] [Related]
29. 1,3-butadiene: cancer, mutations, and adducts. Part V: Hemoglobin adducts as biomarkers of 1,3-butadiene exposure and metabolism. Swenberg JA; Christova-Gueorguieva NI; Upton PB; Ranasinghe A; Scheller N; Wu KY; Yen TY; Hayes R Res Rep Health Eff Inst; 2000 Mar; (92):191-210; discussion 211-9. PubMed ID: 10925842 [TBL] [Abstract][Full Text] [Related]
30. Alkylation of DNA and tissue specificity in nitrosamine carcinogenesis. Montesano R J Supramol Struct Cell Biochem; 1981; 17(3):259-73. PubMed ID: 7328674 [TBL] [Abstract][Full Text] [Related]
31. Binding of dimethylarsinous acid to cys-13alpha of rat hemoglobin is responsible for the retention of arsenic in rat blood. Lu M; Wang H; Li XF; Arnold LL; Cohen SM; Le XC Chem Res Toxicol; 2007 Jan; 20(1):27-37. PubMed ID: 17226924 [TBL] [Abstract][Full Text] [Related]
32. NTP Toxicology and Carcinogenesis Studies of Pentachloroanisole (CAS No. 1825-21-4) in F344 Rats and B6C3F1 Mice (Feed Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1993 Apr; 414():1-284. PubMed ID: 12616284 [TBL] [Abstract][Full Text] [Related]
33. Identification and quantitation of N-(carboxymethyl)valine adduct in hemoglobin by gas chromatography/mass spectrometry. Cai J; Hurst HE J Mass Spectrom; 1999 May; 34(5):537-43. PubMed ID: 10390858 [TBL] [Abstract][Full Text] [Related]
34. Aflatoxin-albumin adducts: a basis for comparative carcinogenesis between animals and humans. Wild CP; Hasegawa R; Barraud L; Chutimataewin S; Chapot B; Ito N; Montesano R Cancer Epidemiol Biomarkers Prev; 1996 Mar; 5(3):179-89. PubMed ID: 8833618 [TBL] [Abstract][Full Text] [Related]
35. Alkylation of protein by methyl methanesulfonate and 1-methyl-1-nitrosourea in vitro. Paik WK; DiMaria P; Kim S; Magee PN; Lotlikar PD Cancer Lett; 1984 May; 23(1):9-17. PubMed ID: 6331636 [TBL] [Abstract][Full Text] [Related]
36. In vivo and in vitro characterization of ethyl methanesulfonate pharmacokinetics in animals and in human. Lavé T; Birnböck H; Götschi A; Ramp T; Pähler A Toxicol Lett; 2009 Nov; 190(3):303-9. PubMed ID: 19695315 [TBL] [Abstract][Full Text] [Related]
37. Disappearance of free SH-groups in hemoglobin of man, rat and rabbit after exposure to alkylating agents in vitro. Neis JM; Van Gemert PJ; Roelofs HM; Henderson PT Toxicology; 1984 Jun; 31(3-4):319-27. PubMed ID: 6740705 [TBL] [Abstract][Full Text] [Related]
38. Inducible protective processes in animal systems: adaptive response to a low dose of methyl methanesulfonate in mouse bone marrow cells. Mahmood R; Vasudev V; Harish SK; Guruprasad KP Indian J Exp Biol; 1996 Jun; 34(6):502-7. PubMed ID: 8792636 [TBL] [Abstract][Full Text] [Related]
39. In vitro induction of micronuclei by monofunctional methanesulphonic acid esters: possible role of alkylation mechanisms. Eder E; Kütt W; Deininger C Chem Biol Interact; 2006 Dec; 164(1-2):76-84. PubMed ID: 17011536 [TBL] [Abstract][Full Text] [Related]
40. Structural characterization by mass spectrometry of hemoglobin adducts formed after in vivo exposure to methyl bromide. Ferranti P; Sannolo N; Mamone G; Fiume I; Carbone V; Tornqvist M; Bergman A; Malorni A Carcinogenesis; 1996 Dec; 17(12):2661-71. PubMed ID: 9006104 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]